NEVVI Medicare utilization intelligence
or

← back

Provider profile

SEMMES, LUETTE M.D.

Dermatology · NPI 1962437590 · SALISBURY, MD

1
Groups
33
Codes · 2024
8,771
Disclosed services

SEMMES, LUETTE is a Dermatology in SALISBURY, MD, a member of 1 medical group, who billed 33 distinct codes to Medicare Part B in 2024.

Groups: FOREFRONT DERMATOLOGY SC (PENSACOLA, FL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

8,771
disclosed services
33
codes billed to Medicare Part B
Prior year · CY2023 9,071 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17000 Destruction of precancer skin growth, 1 growth
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17110 Destruction of skin growth, 1-14 growths
11102 Biopsy of related skin growth, first growth
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
96567 Application of light to destroy precancer skin growth
11103 Biopsy of related skin growth, each additional growth
96372 Injection of drug or substance under skin or into muscle
11200 Removal of skin tag, 1-15 skin tags
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
10040 Acne surgery
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
11900 Injection into skin growth, 1-7 growths
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11601 Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm
11641 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
69100 Biopsy of ear
10060 Simple or single drainage of skin abscess
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
17004 Destruction of precancer skin growth, 15 or more growths
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
11901 Injection into skin growth, more than 7 growths
12042 Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
11621 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.